Lester Rachael 4
4 · CytomX Therapeutics, Inc. · Filed Oct 29, 2025
Insider Transaction Report
Form 4
Lester Rachael
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-10-20+650,000→ 650,000 totalExercise: $3.74Exp: 2035-10-19→ Common Stock (650,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the one year anniversary measured from October 20, 2025 (the "Vesting Commencement Date"), and 1/48th of the shares will vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.